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Introduction  
Substance dependence and mental illness affect millions of adults and adolescents in the United States 
each year1. Substance use disorder, which includes substance dependence, presents a major public 
health concern given the current state of the opioid epidemic and the ongoing risk that alcohol use 
presents to adults and adolescents. The opioid epidemic involves heroin, illicitly-made fentanyl, and 
misuse of legal opioids in the form of prescription pain relievers. Centers for Disease Control and the 
National Institute on Drug Abuse report that 115 people in the United States die each day as a resul t of 
opioid overdose2,3. The estimated economic burden of this epidemic is $78.5 billion per year in costs of 
healthcare, lost productivity, addiction treatment, and criminal justice costs2. The National Institute on 
Alcohol Abuse and Alcoholism report an estimated 88,000 people die each year in the United States 
from alcohol-related causes, making alcohol the third leading cause of preventable death behind 
tobacco and diet and exercise4. SUD poses additional public health concerns due to the increased risk of 
chronic disease for individuals with SUD including cirrhosis, cardiovascular disease, diabetes, pulmonary 
disease, poor wound healing, and impaired immune function5, as well as common comorbidity with 
other mental illnesses and eating disorders.  
Substance use and substance dependence are intimately tied to nutrition: the use of substances 
interferes with adequate food intake in the short term and can alter digestive function and metabolism 
of nutrients in the long term. Despite this established link between substance use and nutrition, 
nutrition services are not always employed in SUD treatment and if they are, the role of the registered 
dietitian in the treatment of SUD is not well defined.  
Like other chronic conditions, substance use disorders are characterized by a genetic vulnerability and 
biological processes that facilitate substance use. As such, treatment of substance use disorders 
warrants similar interventions from a registered dietitian aimed at promoting dietary and behavior 
changes to best facilitate recovery and long-term management. This paper explores how the Health at 
Every Size approach best fits as a model of nutrition practice in the setting of SUD treatment.  
Definition and prevalence   
The National Survey on Drug Use and Health (NSDUH) collects data related to alcohol, tobacco, and drug 
use among those 12 years and older in the civilian, noninstitutionalized population of the United States 
therefore presenting a picture of the current state of substance use in this country. The NSDUH reports 
an estimated 19.7 million people aged 12 and older had a substance use disorder related to alcohol or 
illicit drugs in the year 20171. This estimate includes 14.5 million people with alcohol use disorder and 
7.5 million people with illicit drug use disorder. Among the illicit drug use disorders, the most common 
disorders were for marijuana (4.1 million people) and for prescription pain relievers (1.7 million 
people)1. These estimates from the survey are based on individuals who meet the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for dependence or abuse for 
alcohol or illicit drugs.  
According to the NSDUH, respondents were defined as having alcohol use disorder or illicit drug use 
disorder if they met the DSM-IV criteria for either dependence or abuse. Respondents were defined as 
having substance dependence if they met three or more of the seven dependence criteria1: 
1. Spent a lot of time engaging in activities related to substance use; 
2. Used substance in greater quantities or for a longer time than originally intended; 
3. Developed tolerance; 
4. Made unsuccessful attempts to cut down on use; 
5. Continued use despite physical health or emotional problems associated with use;  
6. Reduced or eliminated participation in other important or previously pleasurable activities 
because of substance use; 
7. Experienced withdrawal symptoms when cutting back or stopping use; 
Respondents who did not meet criteria for dependence were defined as having abuse if they reported 
one or more of the following1: 
1. Problems at work, home, or school because of substance use; 
2. Regularly using the substance and then doing something physically dangerous; 
3. Repeated trouble with the law because of substance use; 
4. Continued use of the substance despite problems with family or friends.  
More recently, the DSM-V combines substance dependence and substance abuse under a single 
diagnosis of substance use disorder6,7. Substance use disorder (SUD) is diagnosed based on a 
pathological pattern of behaviors related to the use of the substance. The diagnostic criteria match the 
DSM-IV dependence and abuse criteria listed previously with a few differences. The DSM-V does not 
include the criterion about repeated legal problems as a result of substance use. The DSM-V replaces 
this criterion with presence of cravings or a strong desire or urge to use the substance. In combining 
substance dependence and substance abuse under a single diagnosis, SUD is diagnosed based on 11 
criteria. The presence of two to three symptoms indicates a mild substance use disorder, the presence 
of four to five symptoms is moderate, and the presence of six or more symptoms is designated a severe 
substance use disorder6.  
Substance misuse is a preferred term over substance abuse. Substance misuse is the use of a substance 
in ways or in quantities that are harmful. It is preferred over substance abuse because it conveys a 
similar meaning without the stigmatizing overtones that are associated with “abuse”8. Addiction is 
another common term with its own definition. Addiction is a brain disease  that is characterized by 
“compulsive substance abuse despite harmful consequences”9. Addiction aligns with severe substance 
use disorder. Substance use disorder encompasses multiple levels of disordered substance use, from 
misuse to dependence to addiction8.  
Alcohol  
The 2017 NSDUH reports that 14.5 million people aged 12 and older live with alcohol use disorder. This 
figure includes 3.4 million young adults aged 18 to 25 (10% of this age group) and 10.6 million adults 26 
and older, about 5% of this age group.  These prevalence numbers are similar to the prevalence of AUD 
in these age groups in 2016. Additionally, the NSDUH reports that alcohol had the highest rate of recent 
(in the last year) substance use initiation with 4.9 million new users1.  
Opioids  
Opioids are a group of chemically similar drugs that includes heroin and prescription pain relievers such 
as hydrocodone, oxycodone, and morphine.  
Opioid misuse and opioid addiction represent a major medical and public health concern with an 
average of 115 Americans dying from an opioid overdose everyday3. Preliminary numbers from the 
Centers for Disease Control estimate that more than 70,000 people died of drug overdoses in 2017 
which represents a 10% increase in overdose deaths from 2016. Opioids were involved in the majority of 
those deaths, more than 48,00010.  
The CDC recently released preliminary numbers that indicate a decrease in the number of deaths due to 
drug overdose. From December 2017 to March 2018, the pace of increase in overdose deaths decreased 
from 10 percent to 3 percent over the previous 12 months10. Despite the beginning of a plateau in 
overdose deaths, there is still work to be done in the prevention and treatment of opioid abuse. After 
alcohol and marijuana, prescription pain killers have the next highest rate of recent (in the last year) 
substance misuse initiation with 2.0 million new misusers1. This equates to roughly 5,500 people per day 
misusing prescription pain relievers for the first time. The NSDUH defines “misuse” as using pain 
relievers without a prescription of one’s own or using a higher dose or using more often than is 
prescribed, even if the reason is to relieve pain1. Among those misusing prescription pain relievers, the 
majority of misusers (62.6%) cited their primary reason for use was pain relief. After that, the most 
common primary reason (for 13.2% of misusers) was to feel good or get high1.  
In contrast, the NSDUH estimates that about 220 people per day used heroin for the first time in 2017 
for a total of 81,000 people aged 12 and older initiating heroin use 1. This estimate is down from 2016 
when the number of estimated new heroin users for the year was 170,000 people among those aged 12 
and older1.  
The 2017 NSDUH estimates that 1.7 million people aged 12 and older (0.6% of this population) had a 
prescription pain reliever use disorder and that 652,000 people aged 12 and older (0.2% of this 
population) had a heroin use disorder. For both classes of opiates, the highest number of substance use 
disorders are seen in those aged 26 and older (compared to categories for individuals 12-17 and 18-25 
years old)1.   
What is considered a current opioid epidemic can be attributed to medical and pharmaceutical industry 
downplay of the addictive potential of opioids in the late 20th century and physicians subsequently over-
prescribing opioids to treat chronic pain. A letter to the New England Journal of Medicine in January 
1980 by two researchers explained that in their analysis of 11,882 patients treated with opioids for pain, 
development of addiction was rare in individuals without history of addiction 11. This letter became one 
of several publications challenging the previous paradigm that opioids are addictive. Instead of 
physicians avoiding opioids, opioid treatment started to become the humane alternative to surgery or 
not treating a patient in chronic pain.  
Oxycontin was introduced in 1996. Manufacturer Purdue Pharma advertised in medical journals and 
created videos directed at patients to market the drug. After the video, opioid prescriptions in the 
United States increased by 11 million. Resources printed in 2000 by the Joint Commission, the non-profit 
agency that accredits hospitals, and sponsored by Purdue Pharma would further validate the thought 
that opioids present low risk of addiction. Purdue Pharma executives would later be charged with 
downplaying Oxycontin’s addictive potential11.  
More recently, opioid users have turned to heroin instead of prescription pain reli evers because heroin 
is cheaper, easier to use, and widely available11. Making this transition more dangerous is the 
introduction of illicitly-made fentanyl. Fentanyl is a synthetic opioid that is 50 times more potent than 
heroin12 and is used in surgical anesthesia and pain treatment. Most of the fentanyl in the drug supply is 
manufactured overseas and mixed with heroin or used to make counterfeit prescription pills12. Because 
of its increased potency, use of fentanyl increases risk of an overdose.  
Substance impact on nutrition  
It is well established that substance use impacts nutrient intake, absorption, and metabolism 5,13,14. 
Substance misuse and substance use disorders are positively correlated with malnutrition 5,13, 
malnutrition worsening with severity of substance use disorder and polydrug use15. Schenker (as quoted 
by Jeynes and Gibson, 2017) defines malnutrition as the “disturbance of form or function arising from 
the deficiency of one or more nutrients”5. Ross and colleagues differentiate between primary 
malnutrition and secondary malnutrition13, both of which apply to those with alcohol use disorder and 
drug use disorder. Primary malnutrition is the inadequate intake of food variety and/or volume while 
secondary malnutrition is an interference in digestion, absorption, metabolism and usage of nutrients 13.  
Malnutrition in this population can be the result of a variety of factors. Variables at play in malnutrition 
include poor food security, low income, and lack of cooking skills5. On a physiological level, malnutrition 
could result from compromised liver function in metabolism and energy storage, decreased appetite, 
inhibited gastric motility, and increased excretion of nutrients secondary to poor absorption 5,15.  
Alcohol 
An estimated 14.5 million people aged 12 an older had alcohol use disorder according to the 2017 
NSDUH1. This number corresponds to 5.3% of the population aged 12 and older or about 1 in 19 people 
of this age group1. de Timary and colleagues report that epidemiological studies have shown that 
alcohol may account for 10% of total energy consumption in alcohol consumers and for more than 50% 
of total energy consumption in those with alcohol dependence16. With such a significant amount of total 
energy coming from alcohol instead of food, it follows that those with alcohol use disorder are at 
increased risk for malnutrition.  
Alcohol impacts nutrition from ingestion to nutrient use. Metabolism of ethanol in the liver consumes 
the electron acceptor NAD+. Consumption of NAD+ in this reaction depletes NAD+ stores for 
macronutrient metabolism and hinders processes like glycolysis, gluconeogenesis, and lipid metabolism. 
When these processes are impaired, the liver cannot efficiently create energy for the rest of the body.  
In addition to impaired macronutrient metabolism, micronutrient deficiencies are a concern in alcohol 
use disorder. Individuals with AUD are at increased risk for micronutrient deficiencies of many of the B-
complex vitamins, vitamins A, C, D, E, K,  potassium, magnesium, selenium, and zinc5. Thiamine (vitamin 
B1) is of particular concern in those with AUD17. Thiamine is required for metabolism of carbohydrates, 
the body’s most efficient source of energy and preferred fuel source for the brain. Alcohol inhibits 
thiamine uptake from the gastrointestinal tract by reducing transcription factors, thereby reducing 
synthesis, for the two transporters that absorb thiamine in the brush border of the small intestine5. With 
fewer transporters, less thiamine is absorbed.  Alcohol also reduces synthesis of the enzyme thiamine 
pyrophosphokinase. This protein changes the thiamine found in food to thiamine pyrophosphate, the 
active form that serves as a coenzyme in metabolic reactions5. Thiamine deficiency is established as the 
primary cause of Wernicke’s encephalopathy and Korsakoff Syndrome5 which often co-occur as 
Wernicke-Korsakoff syndrome. Wernicke’s encephalopathy is the first stage of the syndrome and is 
characterized by confusion, involuntary and impaired eye movement, and lack of muscle coordination. 
Korsakoff syndrome is characterized by amnesia and hallucinations. Thiamine supplementation has been 
shown to relieve symptoms of both, especially Wernicke’s encephalopathy5.  
Magnesium is also depleted in alcohol consumption. In those with AUD, deficiency levels vary from 13% 
to 50%5. Magnesium is a required micronutrient for many metabolic reactions and is of particular 
concern as it relates to thiamine metabolism. Magnesium is a cofactor in the conversion of thiamine to 
thiamine pyrophosphate, the metabolically active form of thiamine5. If sufficient thiamine is available 
without adequate magnesium, carbohydrate metabolism is impaired. This micronutrient relationship 
should be considered in those with Wernicke’s encephalopathy and others for whom thiamine 
supplementation is indicated. 
Niacin, another member of the B-complex of vitamins, is likely to be deficient in those with AUD5. Niacin 
is found in protein sources such as meat products which may be lacking in the diets of those with AUD 
given the likelihood of overall poor intake. The body can synthesize niacin from the amino acid 
tryptophan provided that tryptophan is included in the diet. This conversion of tryptophan to niacin 
takes place in the liver and requires micronutrient cofactors thiamine, riboflavin, pyridoxine, and zinc5. If 
liver function is compromised as a result of long-term alcohol use or if any of these cofactors are 
unavailable, niacin deficiency can result.  
Subjects with AUD are also found to have low levels of vitamins A, C, and E5. Vitamin A functions as an 
antioxidant in the form of carotenoids and regulates expression of genes as retinoic acid.  Levels of 
retinoic acid are found to be low in those with AUD5. The conversion of ethanol to acetic acid and the 
conversion of retinol to retinoic acid compete for a metabolic pathway. Both conversions require alcohol 
dehydrogenase to catalyze the reaction in the liver and both require NAD+ as an electron acceptor. If 
NAD+ supplies are depleted in the course of metabolizing consumed ethanol, there will be insufficient 
NAD+ to convert retinol to retinoic acid. Increased levels of ethanol to detoxify could explain the 
decreased amounts of retinoic acid in individuals with AUD. Low levels of antioxidant vitamins C and E 
and carotenoids could be the result of poor overall diet observed in AUD and poor intake of foods that 
contain these nutrients. Decreased levels of antioxidants impair the body’s ability to remove toxins and 
regulate inflammation, tipping the body’s regulatory processes toward oxidative damage . Oxidative 
damage is involved in the development of chronic disease like diabetes and atherosclerosis as well as 
aging and damage to DNA.   
Chronic alcohol use is also associated with physical changes that impact nutrition status. Chronic alcohol 
use can cause mucosal damage in the mouth, esophagus, stomach, and intestine, as well as 
inappropriately increase intestinal permeability5. As alcohol consumption increases, gastric acid 
secretion may also increase, leading to hyperchlorhydria and atrophic gastritis17. These conditions 
impair the absorption of nutrients, particularly thiamine and vitamin B12. Consequences of a vitamin 
B12 deficiency include pernicious anemia and nerve damage. Lack of vitamin B12 would result in 
numbness and tingling in extremities, poor muscle control, and impaired memory 17.  
Replacing nutrients with alcohol and the maldigestion, malabsorption, and poor utilization of nutrients 
that occurs as a result of chronic alcohol use creates a pathological cycle of malnutrition in those with 
alcohol use disorder.  
Individuals entering treatment for alcohol use disorder are likely coming from a place of appetite 
dysregulation and irregular eating patterns as a result of their substance use. As mentioned previously, 
alcohol may account for as much as 50% of energy intake in those with AUD, leaving little room for 
normal eating patterns. Researchers have observed that alcohol craving and blood levels of appetite-
regulating hormones are correlated, again demonstrating a link between alcohol use and nutrition.  
de Timary and colleagues conducted a study evaluating energy intakes, appetite-regulating hormones, 
and BMI among those admitted to inpatient for alcohol withdrawal and rehabilitation. The study 
compared alcohol-dependent subjects to control subjects. The researchers observed that alcohol-
dependent subjects show a significantly lower frequency of eating breakfast and lunch at the beginning 
of withdrawal compared to controls, but frequency of dinner was similar to that of controls. When 
measured at Time 3 (16 days from the start of withdrawal), frequency of breakfast and lunch among 
alcohol-dependent subjects had increased. The study also observed that among alcohol-dependent 
subjects, there was a positive correlation between energy intake from non-alcoholic sources and energy 
intake from alcoholic sources. After splitting the study group along the median alcohol intake of 12.5 
kcal ethanol/kg/day, the researchers observed a difference in total energy intake above and below this 
marker. Below 12.5 kcal/kg/day, energy intake from nonalcoholic sources is decreased to compensate 
for the alcohol intake, maintaining a balance in energy intake. Above this median value, total energy 
intake exceeded “norms” as energy from non-alcoholic sources increased with energy from alcoholic 
sources. Furthermore, the study found that as alcohol intake increases (in kcal  of ethanol/kg/day), BMI 
and weight of alcohol-dependent subjects decrease, suggesting that there is an interaction between 
alcohol and energy metabolism. The study measured respiratory quotient among alcohol-dependent 
subjects at different times throughout the withdrawal period. Early in withdrawal the RQ of AD subjects 
was low, indicating the body favored lipid oxidation for energy. When measured after withdrawal, RQ 
had increased indicating a shift away from lipid metabolism. The study observed higher basal metabolic 
rates among AD subjects early in withdrawal and decreased basal metabolic rates after withdrawal. 
Favoring lipid oxidation and higher BMR during heavy alcohol use  could explain the negative correlation 
between alcohol intake and BMI observed in AD subjects. This association could also be attributed to 
impaired nutrient absorption in the gastrointestinal tract secondary to alcohol use. Results from this 
study are consistent with previous research that reports complete recovery of fat mass within three 
months of abstinence.  
Compared to controls, anorexigenic and orexigenic hormones differed among alcohol dependent 
subjects. de Timary and colleagues observed higher levels of anorexigenic hormones leptin, insulin, and 
PYY and decreased levels of the orexigenic hormone ghrelin in AD subjects. The researchers, however, 
also observed a significant decrease in the anorexigenic hormone GLP-1 which would be expected to 
have a positive effect on appetite. Taken together, these hormone level differences could help explain 
decreases in food intake in individuals with alcohol dependence. This finding contradicts the results of 
the study among heavy alcohol consumers that observed higher total energy intakes among individuals 
consuming more than 12.5 kcal ethanol/kg/day. This suggests that there is a deeper interaction between 
ethanol and appetite that remains to be explored.  
Opioids 
Opioid misusers are at increased risk of malnutrition, low body weight and BMI, and essential vitamin 
and nutrient deficiencies15,18. In individuals with drug use disorders, malnutrition or nutrient deficiencies 
may more often result from inadequate intake in food volume and variety and dysfunctional eating 
patterns. Unlike alcohol, drug use does not compromise the structure of the digestive tract, but drug 
users do experience poor nutrient absorption as a result of diarrhea, constipation, and vomiting5 
secondary to substance use. Micronutrients of concern in opioid misuse include thiamine, riboflavin, 
niacin, vitamins A, C, D, and E,  magnesium, calcium, copper, and iron5 – micronutrients essential for 
energy production, antioxidant function, bone health, and oxygen transport throughout the body.  
Contributing to malnutrition among opioid misusers, particularly heroin users, is a preference for cheap, 
sweet, convenient foods. Cravings for sweet foods are typically higher in those actively using drugs 
compared to methadone maintenance15, but individuals on methadone maintenance, a medication-
assisted treatment for opioid addiction, still report high cravings for sweet foods. While sweet 
convenience foods certainly have a place in a healthy diet, they don’t provide many essential 
micronutrients. Irregular eating patterns noted during active heroin use further exacerbates 
malnutrition. Drug misusers report eating only once or twice per day15,18 and report deriving little 
pleasure from food or eating during active heroin use. Drug misusers also report little social eating 
which generally decreases food intake18.   
Irregular eating patterns during drug use could be a manifestation of a variety of  factors contributing to 
lack of desire to eat. Opioids inhibit gastric motility, resulting in constipation which could decrease 
appetite15. Individuals misusing drugs might also have a history of eating disorders or other mental 
health conditions like depression, which decreases regular food intake and reduces appetite. Other 
factors with nutrition implications noted in this population include lack of access to adequate food or 
cooking facilities (due to homelessness or poor housing) and preoccupation with the drug which results 
in giving little thought to food.  
Dental caries among drug misusers further contributes to poor nutrition status15,19. In general, dental 
caries contribute to poor nutrition status because caries can make eating painful and if left untreated, 
can cause infection of the tooth and gums and tooth loss. Factors driving dental caries among opioid 
misusers include less frequent brushing while using the substance and preference for sweet foods while 
using. From one report, 66% of users reported brushing teeth less often when using heroin than when 
not using and 84% reported increase in sweets consumption when using15. Opiate use, methadone and 
heroin, is independently associated with dental pathology after controlling for frequency and quality of 
dental care19. This report does not indicate whether the study controlled for personal or professional 
dental care, or both. In light of that, infrequent visits to the dentist could be another factor driving poor 
dentition in this population. Methadone is 50% sugar and could also contribute to dental caries, 
although there isn’t literature to support this. The sugar content of methadone is not likely the sole 
cause of caries19.   
Pharmacological treatment 
Substance use disorders are chronic mental illnesses with multifactorial etiologies. As such, treatment 
should also be multifactorial with the collaboration of multiple disciplines. Pharmacological 
interventions to ease withdrawal symptoms in conjunction with behavioral therapy, social support, and 
counseling for lifestyle changes present a combination most likely to result in treatment adherence and 
prevent relapse20.  
Alcohol Use Disorder 
There are three drugs approved by the United States Food and Drug Administration for the treatment of 
alcohol use disorder: disulfiram, naltrexone, and acamprosate.  
Disulfiram was approved for the treatment of alcohol dependence in 1951. The medication works by 
inhibiting the enzyme acetaldehyde dehydrogenase in the liver that metabolizes acetaldehyde to acetic 
acid20, a downstream reaction in the metabolism of alcohol. This causes buildup of acetaldehyde which 
produces unpleasant side effects that characterize the “disulfiram reaction” including flushing, 
headache, nausea, vomiting, diaphoresis, and lightheadedness21. Disulfiram is an alcohol-deterrent 
meaning that rather than reducing cravings for alcohol or reducing euphoric feelings associated with 
alcohol intake, disulfiram produces these immediate and potentially severe effects when alcohol is 
consumed which should deter the individual from consuming alcohol. Even small amounts of alcohol are 
enough to elicit this response when taking disulfiram. Because it i s a deterrent, medication adherence is 
required for disulfiram to be effective in treatment. This medication should not be prescribed early in 
treatment when an individual is struggling to maintain sobriety. Disulfiram is a useful pharmacologic 
treatment for individuals whose goal is complete abstinence from alcohol rather than a reduction in 
amount of drinking or heavy drinking days21. 
Naltrexone is the second drug approved by the FDA for the treatment of AUD. Naltrexone is an opioid 
receptor antagonist. Because it blocks the opioid receptors in the brain that alcohol targets, it inhibits 
the euphoric effects of alcohol consumption, thereby reducing alcohol cravings and facilitating 
abstinence from alcohol21. This mechanism of action also means that naltrexone is an effective 
pharmacological treatment for opioid dependence. As an opioid receptor antagonist, naltrexone would 
be contraindicated for individuals in AUD recovery who take prescription opioids for pain management. 
When taken orally, naltrexone can have hepatotoxic effects. In response to this, a form of the drug that 
can be delivered via intramuscular injection was developed and approved by the FDA in 200621. The 
injection only needs to be administered monthly and may be a viable option in those at risk of not 
adhering to pharmacotherapy.  
Acamprosate is the third FDA-approved drug for treatment of AUD, and its mechanism of action is still 
unknown. Some research indicates that acamprosate reduces the dopamine release in the brain in 
response to alcohol consumption, thereby reducing the reward associated with alcohol intake. Other 
research suggests that the drug prevents relapse by reducing alcohol withdrawal symptoms like sleep 
and mood instabilities. In spite of its still undefined mechanism, acamprosate was approved in 2006 and 
meta-analyses validate its efficacy in AUD treatment20.  
Opioid Use Disorder 
The Food and Drug Administration has approved three drugs for the treatment of opioid abuse: 
buprenorphine, methadone, and naltrexone. Naloxone is another FDA-approved medication and is 
specifically used in the setting of an opioid overdose.   
Experience of opioid withdrawal in treatment often leads to relapse. In light of this, supervised opioid 
maintenance with medication to mitigate withdrawal symptoms often becomes the first line of defense 
to prevent relapse and is considered an effective therapy in opioid use disorder20. The goals of opioid 
maintenance with an opioid agonist are “prevention or reduction of withdrawal symptoms, drug craving, 
and relapse to addictive drug use, but also the restoration of physiological function disrupted by  drug 
abuse”20.  
Two common medications used in medication-assisted treatment (MAT) for opioid use disorder are 
methadone and buprenorphine. Methadone is a full agonist at the µ-opioid receptor, the same receptor 
in the brain that opiate drugs target, and has a longer half-life (24-36 hours) than opioids involved in 
abuse, such as heroin or morphine. Methadone exerts a steady state effect compared to the more 
volatile effects of opiates of abuse. Methadone also lessens the pain associated with withdrawal 
symptoms while blocking the euphoric effects of opiates like heroin or prescription pain relievers 20,22. 
A second opioid receptor agonist is buprenorphine. Unlike methadone, buprenorphine is a partial 
agonist at the µ-opioid receptor, characterized by a slow dissociation from the mu receptor. This slow 
dissociation contributes to the long-acting nature of the drug20. Long-acting buprenorphine has less 
abuse potential than methadone because lower doses can be used to achieve similar effects. 
Buprenorphine has shown to be effective in reducing opioid cravings and severity of opiate withdrawal 
symptoms without having the euphoric effects of full opioids. A known limitation of the medication is 
the limited efficacy in cases of severe opiate dependence20.  
In contrast to methadone and buprenorphine, naloxone is a mu receptor antagonist. Naloxone blocks 
the mu receptor and displaces opioids currently bound at those receptors. As a result of blocking the mu 
receptor and displacing any currently-bound opiate, administration of naloxone results in immediate 
withdrawal symptoms. Naloxone is used foremost in the treatment of opioid overdoses. Given as an 
injection or as a nasal mist, it quickly crosses the blood-brain barrier and can reverse opiate-induced 
respiratory depression within one to two minutes20. In April 2018 the Surgeon General released a 
statement urging more Americans to carry the potentially life-saving drug as one step toward reducing 
deaths from opioid overdose23. Many first responders already carry the drug. The Surgeon General’s 
recommendation is particularly applicable to friends and family of and professionals working with those 
who are at risk of an opioid overdose, including individuals in outpatient treatment for opioid misuse 
and those who take high doses of prescription opioids for medical conditions. All states have passed 
laws to increase access to naloxone such as allowing physicians to write third party prescriptions for 
friends and family of those at risk of an overdose and permitting the distribution of naloxone in 
community settings24. In many states it is possible to request naloxone from a pharmacy without a 
prescription25.  
RD role in treatment 
Nutrition services in SUD treatment setting 
In 1990 the Academy of Nutrition and Dietetics (formerly the American Dietetic Association) published a 
statement advocating for the use of the registered dietitian in the treatment of substance use disorders , 
asserting that improved nutrition status during recovery improves brain health and emotional 
functioning to make treatment more effective, reduces alcohol and drug cravings, and prevents 
relapse26. Little was done in the way of incorporating the dietitian into the SUD treatment setting on a 
broad scale so dietitians are still underutilized in SUD treatment facilities14, despite what is known about 
malnutrition and SUD. In treatment centers that utilize nutrition services, nutrition education may not 
be delivered by a registered dietitian. Instead, a counselor, social worker, or non-credentialed 
nutritionist may take on the role of nutrition counseling27. It is also not uncommon for the only nutrition 
information that patients receive in treatment to be written by Alcoholics Anonymous, which 
recommends eating sweet foods to curb alcohol cravings14. This lack of adequate nutrition information 
in recovery creates a vacuum in addiction treatment that registered dietitians can fill with group and 
individual nutrition education and become an integral part of the treatment team.  Nutrition education 
and improving the food environment during treatment can be powerful tools in the treatment of 
substance use disorders by decreasing likelihood of relapse and empowering patients with the 
knowledge to make positive food choices within their means. A nourished brain will be more receptive 
to recovery, decreasing the likelihood of relapse28. Studies show that nutrition education in the 
treatment facility improves dietary intake compared to baseline29 and individualized nutrition counseling 
within comprehensive nutrition education programs significantly improves the three-month success rate 
of substance abuse treatment units28. Registered dietitians should be involved in treatment at the 
residential, partial hospitalization, and outpatient levels of care.  
One of the initial goals in nutrition care during SUD treatment is adequate calorie intake. Patients often 
enter treatment in a state of malnutrition, having substituted the substance for nutrition or not making 
nutrition a priority. The registered dietitian plays a role here in ensuring that patients entering 
treatment are assessed and are being served meals that meet their estimated needs to support 
recovery.  
Beyond the initial requirement for adequate nutrition, the dietitian has an important role in nutrition 
education. Patient education is routine when patients are newly diagnosed or need additional support 
for conditions like diabetes or congestive heart failure. Given that substance use disorder is a chronic 
condition, individuals with SUD should be afforded the same benefits as patients with other, less 
stigmatized chronic conditions. As is the case for other chronic conditions, nutrition education in this 
setting should be tailored to the specific risk factors in the SUD population such as potential for 
malnutrition in substance use and disordered eating behaviors. The dietitian should consider group or 
individual education topics focusing on proper diets for co-occurring conditions with SUD such as 
irritable bowel syndrome, hepatitis C, and chronic constipation18,30. The AND proposes additional topics 
for nutrition education in SUD treatment: eating for mental health to discuss nutrient deficiencies that 
impact mental health; anti-inflammatory foods; emotional eating; cravings and physiologic appetite 
control; the importance of fiber; the gut microbiome; nutrition myths; exercise in recovery; mindful 
eating; budgeting and shopping. Caffeine and nicotine are often abused during recovery  or active 
substance use14,18. Use of nicotine is a disordered behavior if it is used to suppress appetite. AND 
recommends education in this setting about safe use of caffeine and nicotine and strategies for 
reduction or cessation14.  
Grant and colleagues conducted a study of treatment facilities to objectively measure the association of 
nutrition education in treatment and SUD treatment outcomes. Their study used changes in Addiction 
Severity Index (ASI) scores to quantify the association. The ASI is a validated instrument that measures 
addiction severity based on seven problem areas related to substance misuse: alcohol, drug, medical, 
legal, employment, family/social, and psychiatric problems. The ASI is administered to patients at 
admission and can be re-administered at follow-up points throughout treatment. Changes in ASI scores 
provide a measurable degree of change in each of the domains as a result of treatment. Grant and 
colleagues found that when nutrition education services were provided in treatment, significant 
improvements in ASI scores from 55% to 99% were noted for the medical, psychiatric, and family/social 
domains. In fact, when nutrition services were not provided in treatment, scores for these same 
domains worsened by a range of 67% to 104%28.  
In another intervention study, six different treatment facilities offered weekly nutrition and cooking 
education to male residents in SUD treatment. Participants in all study sites reported high levels of 
satisfaction with nutrition and cooking education, with percentage of individuals reporting satisfaction 
rarely dropping below 80%31. Nutrition often takes a back seat for someone during active substance 
misuse so patients will likely become more concerned with their nutritional status after drug or alcohol 
use is reduced when a patient realizes they look underweight, are given a drug use-related diagnosis like 
hepatitis C, or have difficulty sleeping18. This increased interest in nutritional status lends itself to an 
interest in nutrition and cooking education. Cooking and eating a balanced diet in SUD treatment can 
have a therapeutic effect of increasing self-esteem, health, and social relationships18. Patients enjoy an 
overall healthier diet when they can cook for someone else or eat in a social setting18. In spite of the 
noted benefits of cooking, barriers to preparing food outside of treatment still need to be validated and 
addressed, such as poor access to cooking equipment at home or financial constraints.   
The food service in a treatment program is a strong predictor of intake behavior among partici pants14. 
The registered dietitian could play a key role in SUD treatment services by improving and managing the 
food services of the treatment center. Interventions that address the food environment in the 
treatment center can be another avenue to facilitate behavior change and good nutrition among 
patients. One nutrition intervention in six SUD treatment facilities added daily fruit and vegetable 
options and 100% fruit juice to the facility menus, reduced the number of sugary beverages available, 
and reduced the amount of fried food available. All six sites saw improvement in daily fruit and 
vegetable intake among residents, although results were not significantly different from baseline. The 
four sites with “high implementation” saw significant reduction in intake of daily servings of fats, oils, 
and sweets from baseline as a result of food service changes31. There is a lack of research examining this 
type of intervention in SUD treatment14, but studies like this provide a foundation for future 
investigations and provide early signs of evidence for the utility of a registered dietitian in food service in 
SUD treatment.  
Eating disorder-informed treatment 
The role of the registered dietitian in the treatment of SUD goes beyond providing general nutrition 
services. Part of what makes the dietitian’s role unique in the SUD treatment setting is the responsibility 
to provide nutrition guidance from an eating disorder-informed perspective. In other words, the 
dietitian should approach nutrition in this setting from a position that does not emphasize weight loss 
and dieting due to the high rate of comorbidity between eating disorders and substance use disorders. 
Eating disorders and substance use disorders often co-occur32–35 – those with eating disorders are at an 
increased risk for a substance use disorder and vice versa14. In their review of the National Comorbidity 
Survey Replication (NCS-R), a nationally representative survey of the US household population, Hudson 
and colleagues found that occurrence of the eating disorders anorexia nervosa, bulimia nervosa, or 
binge eating disorder was positively correlated with co-occurrence of a substance use disorder32. From 
their analysis, prevalence of SUDs in those with an anorexia nervosa, bulimia nervosa, and binge eating 
disorder was as high as 27%, 37%, and 23%, respectively32. People with SUD are 10 times more likely to 
have an eating disorder than the general population36. Eating disorder symptoms in the SUD population 
appear to be nuanced. Available research suggests that individuals with bulimic ED symptoms such as 
bingeing and purging (present in bulimia nervosa, binge eating disorder, and anorexia nervosa – 
binge/purge subtype) are more likely to abuse substances than individuals whose primary ED symptom 
is food restriction. Available studies reveal that a median prevalence of 20% of people with SUD have a 
history of bulimia nervosa or other purging-related disorder. By comparison, anorexia nervosa or sub-
clinical food restriction behaviors are present in an estimated 10% of those with SUD35.  
Eating disorders and substance use disorders present as unique diagnoses but they have similar roots in 
their etiologies. In addition to genetic predisposition for both, individuals with EDs or SUDs have often 
experienced trauma that contributed to the development of their ED or SUD. Experience of childhood 
sexual abuse is a particularly important risk factor for the development of bulimia nervosa and SUD, 
regardless of whether the ED or SUD manifests first35. After experiencing trauma, behaviors associated 
with EDs and SUDs become mechanisms for the individual to cope with the subsequent anxiety, shame, 
or depression that develops. If the two diagnoses co-occur, symptom substitution is common in 
treatment of both ED and SUD. Treatment of the ED often sees resurgence of the substance misuse. 
Likewise, people entering SUD recovery may turn to other unhealthy coping mechanisms like eating 
disorder behaviors to numb uncomfortable emotions that resurface with abstinence from substance 
use37. Alcohol and heroin are among the substances most frequently abused by people with eating 
disorders or sub-clinical ED symptoms37. In a report of 204 women admitted for inpatient treatment of 
SUD, presence of eating pathology predicted poorer treatment outcomes and a greater probability of 
relapse35.  
Coming from a state of malnutrition or appetite dysregulation, it’s likely that individuals in SUD recovery 
will experience changes in their bodies when they’ve stopped using the substance and begun to 
normalize their eating and increase calories from food. Individuals on methadone maintenance report 
improved appetite and meal consumption. Individuals often gain weight and are often at a higher body 
mass index (BMI) during methadone maintenance, possibly secondary to cravings for sweet foods that 
persist during methadone treatment14,15. Those on methadone maintenance tend to choose large 
amounts of dairy foods15 and sweet foods19 and low quantities of fruits and vegetables.  
These body changes can be distressing, especially for those with pre-existing body image concerns. For 
many, there is a fear of weight gain in recovery. The Academy of Nutrition and Dietetics reports that in 
one sample of 297 females, 70% reported concerns about weight gain in recovery and reported using 
inappropriate restricting or purging behaviors to counteract weight gain. Examples of behaviors from 
this sample included exercising, dieting, starvation, vomiting, enemas, consumption of energy drinks, 
and use of diet pills, cigarettes, laxatives or drugs in efforts to lose weight14. Excessive cigarette use 
during SUD recovery is common because nicotine can act as an appetite-suppressant14. These behaviors, 
when used to manipulate weight or suppress appetite, are disordered eating behaviors.  
Commonly-reported use of eating disorder behaviors in the SUD treatment setting underscores the 
delicate balance the dietitian must find between reinforcing normal eating patterns and having 
compassion for the real fears that patients have around weight gain in recovery. This population is also 
particularly vulnerable to dieting messages ubiquitous in the media and in public health messaging. 
Patients are often coming from a state of malnourishment and unable to think critically about nutrition 
messaging. They may feel guilty about the way they have treated their bodies while using substances. 
Patients may feel pressure from themselves or from family to “get healthy” and they may not view 
weight gain in abstinence as meeting that goal30. Susceptibility to dieting messages increases risk for 
disordered eating behaviors and the dietitian must be able to screen for and recognize these behaviors. 
Weight gain in recovery can be a trigger for substance use relapse. The dietitian can address these fears 
by normalizing regular eating patterns and providing nutrition education from a weight-neutral 
perspective30. Ethical treatment of eating disorders does not include dieting messaging or 
micromanagement of food intake, but rather reinforcement of healthy behaviors to restore a healthy 
body weight for the individual. Given the strong risk for overlap of EDs and SUDs, substance use disorder 
should also be treated without diet and weight loss messaging. 
Reasons to not promote dieting in SUD treatment 
High risk for co-occurrence of eating disorders and disordered eating is reason enough to take an 
approach to nutrition in the SUD treatment setting that does not focus on weight. To further make the 
case for a weight-neutral perspective, research shows that attempts to manipulate weight through diet 
and exercise are not only futile, but also harmful. Research indicates that diets do not lead to 
sustainable weight loss38,39. “Dieting” is defined in the literature as the severe restriction of caloric intake 
in order to lose weight39. Studies show that dieting leads to weight loss in the short term, but this weight 
loss is not maintained. In the long-term, evidence demonstrates that dieters regain the weight they 
initially lost, sometimes gaining more whether or not they continue the diet or exercise regimen39,40. In 
their review of the long-term outcomes of dieting, Mann and colleagues identified 14 diet studies that 
followed participants for at least four years after a diet. In analyzing the outcomes for all of the subjects 
in the 14 studies, “The average weight loss on these diets was 14 kg (30.8 lb), and by the long -term 
follow-up participants had gained back all but 3 of those kilograms (6.6 lb)”39. In eight of the diet studies 
from this analysis, an average of 41% of participants weighed more at follow-up than they did before the 
diet. The rate of participants weighing more at follow-up compared to baseline ranged from 29% to 64% 
among the participants in the studies being compared in this analysis39. In two of those studies, more 
than half of participants weighed more at the long-term follow-up after the diet than before. Studies 
that conclude that diets lead to long-term weight loss often confound diet and exercise. Participants in 
studies who engage in exercise are more successful at long-term weight loss compared to those 
participants who exclusively restrict calories39.  
What’s more, evidence does not show that long-term weight loss improves health independent of other 
health-promoting behaviors. This is partly because research has yet to prove that long-term weight loss 
is possible for a significant number of people40. Without that, it cannot be definitively concluded that 
weight loss improves health in the long term. In studies that conclude that weight loss improves 
biomarkers, the weight loss is accompanied by changes in behavior like improved diet or increased 
exercise. In a study evaluating weight loss and type 2 diabetes, participants lost weight and improved 
glycemic control. The study found that participants’ glycemic markers reverted to starting values six to 
eighteen months after the intervention even when weight loss was maintai ned. This result suggests that 
weight itself is not responsible for improved health outcomes40. Behaviors are more important than 
weight for improving health. Biomarkers like blood pressure, blood lipid profile, and insulin sensitivity 
can be improved with behavior change, whether or not weight is lost40. Given the evidence, managing 
weight should not be the focus in SUD recovery, but rather the dietitian should reinforce healthy 
behaviors surrounding food and exercise to facilitate recovery independent of weight.  
Available research rejects the traditional paradigm that dieting leads to better health and sustainable 
weight loss. What’s more, available research validates that weight cycling leads to poorer health 
outcomes than weight itself. Weight cycling is the repeated loss and gain of weight, causing the 
individual’s weight to cycle up and down over time. Cycling can occur at any weight, but repeated 
attempts to lose weight are more common among individuals in the obese BMI category40. Weight 
cycling is the most common result of dieting and is associated with increased cardiovascular morbidity 
and mortality40. Weight cycling is known to increase inflammation which increases risk for other chronic 
diseases40. Weight cycling is also positively associated with dyslipidemia and insulin resistance41.  
Beyond weight cycling, dieting is associated with other negative health outcomes. Dieting reduces bone 
mass, increasing risk for osteoporosis in people within normal weight and obese BMI categories. Dieting 
also results in increased cortisol production and psychological stress that comes with micromanaging 
food intake and exercise. Elevated cortisol and psychological stress increase risk for chronic disease40.      
Placing value on weight loss in the setting of SUD treatment, or any setting, reinforces anxiety and fear 
around weight gain, an outcome that many individuals in SUD treatment experience. It’s also possible 
that valuing weight loss or thinness might reinforce substance misuse if that’s how an individual has 
previously maintained a lower weight. The dietitian working in SUD treatment should be prepared to 
respond in a productive way to the sentiment “I’d rather be thin and addicted than fat and sober”30.  
Health at Every Size and intuitive eating as models for nutrition practice in SUD treatment 
Because nutrition services are underutilized in the SUD treatment setting27,28, there is not a well-defined 
scope of nutrition services for this population. This void creates the opportunity to establish an 
evidence-based protocol with the greatest potential for positive health outcomes. That nutrition 
practice is taking a weight neutral approach to nutrition in SUD treatment, using Health at Every Size 
and intuitive eating as models for practice. Given the vulnerability of this population and the co-
occurrence of eating disorders, taking the focus in treatment off  body shape and weight and instead 
focusing on positive behavior change creates a foundation for the most successful treatment outcomes. 
Redirecting focus away from diets and weight also complies wi th the registered dietitian’s responsibility 
to provide ethical and evidenced-based nutrition information based on the research that shows the 
harmful and ineffective nature of diets.  
Health at Every Size is a philosophy that shifts focus from weight to health. HAES teaches that regardless 
of current body weight or changes in body weight, an individual can engage in behaviors that improve 
health.  
“HAES encourages body acceptance as opposed to weight loss or weight maintenance”40. Available 
research refutes the conventional belief that weight loss improves health. Encouraging body acceptance 
is particularly important for those in SUD recovery as their bodies change in response to adequate 
nutrition and normal eating. Body acceptance opens the door for folks in SUD treatment to pursue more 
effective avenues to health, instead of attaching a healthy sobriety to a certain weight. In encouraging 
body acceptance, the dietitian also teaches self-compassion which proves to be a far more effective 
motivator for behavior change than shame40. Like in eating disorder treatment, patients are taught to 
accept their body as it is right now, even if appearance differs from a desired weight or shape. In this 
way, patients can move from trying to manipulate their bodies to engaging greater self-care. Armed 
with adequate nutrition knowledge, self-acceptance and self-compassion prove to increase an 
individual’s ability to care for themselves and implement lasting behavior change 38,40,42.  
“HAES supports reliance on internal regulatory processes, such as hunger and satiety, as opposed to 
encouraging cognitively-imposed dietary restriction”40. In other words, HAES encourages intuitive 
eating, the practice of making eating decisions based on internal cues rather than external diet or food 
rules and recognizing that all foods serve a variety of purposes (energy, satisfaction, etc.)43. HAES and 
intuitive eating encourage people to increase awareness of their body’s response to food and make food 
decisions based on this attunement to bodily cues, paying attention to hunger, fullness, satisfaction, 
mood, energy levels, bowel movements, and pleasure.  Intuitive eating is associated with improved 
nutrient intake, reduced eating disorder symptomology, and improved body image40,43. A HAES and 
intuitive eating model challenges black and white thinking around food. Folks in SUD treatment might 
feel shame around the way they treated their bodies while using substances and might view maintaining 
a “perfect diet” as the way to achieve health in sobriety – a way to “make up” for time spent using30. 
Knowing that a perfect diet doesn’t exist, the dietitian can use HAES and intuitive eating to reduce this 
rigidity, challenge conventional thinking, and make room for all foods in a balanced diet.  
Taking a HAES approach to nutrition in SUD treatment allows nutrition services to be adaptable  to a 
variety of demographics among folks seeking treatment. Patients can hear the same weight-neutral 
message and implement recommendations in ways within their means to improve diet, sleep 
adequately, and engage in enjoyable exercise. Implementing HAES and intuitive eating-based nutrition 
services in SUD is also the ethical approach given the high likelihood of SUD and ED co-morbidity. It is 
well-documented that an intuitive eating approach reduces disordered eating behaviors38,43. Reducing 
disordered eating behaviors, normalizing eating habits, and encouraging self-compassion has the 
greatest potential for positive SUD treatment outcomes.  
Barriers to nutrition services in SUD treatment   
Despite the existing evidence of the benefits of nutrition services in SUD treatment, nutrition services 
are still underutilized. One of the reasons for this is the idea that folks seeking treatment are only 
looking to address the initial crisis of detoxing from their substance. They are not seeking additional 
services like nutrition education or counseling or ready for multiple health behavior changes14. A study 
of SUD treatment facilities in the Los Angeles area reported additional barriers. This study reported that 
facilities were satisfied with the levels of care that they offered and did not perceive a need for 
additional care, facilities had budgeting constraints, or the facility perceived a difficulty in care team 
coordination with nutrition services. Other facilities had never considered nutrition as part of their 
treatment plan27. Nutrition services in this setting may not be covered by insurance, leaving the  cost of 
implementation to the facility14. If nutrition services are included in the treatment setting, there could 
be additional barriers to efficacy. Resident turnover can change the group dynamic which could impact 
group education settings. Staff buy-in to the importance of nutrition services in this setting is also 
critical. As staff encourages and prioritizes nutrition services, patients are  more likely to participate and 
benefit31. 
Conclusion 
Individuals with substance use disorder are at increased risk of malnutrition. Alcohol use disorder 
increases risk of malnutrition due to poor nutrient absorption and utilization, as well as decreased intake 
of food volume and variety. Malnutrition in opioid use disorder often results from irregular eating 
patterns that lead to overall inadequate food intake and persistent cravings for nutrient-poor foods. 
Adequate nutrition facilitates recovery and prevents relapse. Despite what is known about the links 
between substance use and nutrition, registered dietitians are still underutilized in the treatment of 
SUD. When nutrition services are implemented, available research touts the benefits of nutrition 
interventions in this setting. I propose that dietitians regularly participate in the treatment of SUDs to 
provide nutrition education and nutrition counseling to patients seeking treatment, as well as manage 
the food service within treatment facilities. I also emphasize the need for dietitians in this space to be 
educated on the critical intersection of SUDs and eating disorders and to tailor any nutrition 
intervention accordingly. The most effective and evidenced-based way to do this is to use Health at 
Every Size and intuitive eating as models for practice, ultimately emphasizing healthy behavior change 
and removing focus from body weight and shape. There is certainly space for dietitians on the team in 
SUD treatment to lay a solid nutrition foundation for a healthy recovery and treat SUD not as a moral 
failure on the part of the individual, but rather as a chronic disease that requires education and long-
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